DE69943058D1 - Loslösendes protein 5 - ucp5 - Google Patents
Loslösendes protein 5 - ucp5Info
- Publication number
- DE69943058D1 DE69943058D1 DE69943058T DE69943058T DE69943058D1 DE 69943058 D1 DE69943058 D1 DE 69943058D1 DE 69943058 T DE69943058 T DE 69943058T DE 69943058 T DE69943058 T DE 69943058T DE 69943058 D1 DE69943058 D1 DE 69943058D1
- Authority
- DE
- Germany
- Prior art keywords
- polypeptides
- present
- ucp5
- nucleic acid
- soluble protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11028698P | 1998-11-30 | 1998-11-30 | |
| US12958399P | 1999-04-16 | 1999-04-16 | |
| US14388699P | 1999-07-15 | 1999-07-15 | |
| PCT/US1999/025947 WO2000032624A2 (en) | 1998-11-30 | 1999-11-03 | Uncoupling protein 5 - ucp5 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69943058D1 true DE69943058D1 (de) | 2011-02-03 |
Family
ID=27380826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69943058T Expired - Lifetime DE69943058D1 (de) | 1998-11-30 | 1999-11-03 | Loslösendes protein 5 - ucp5 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6967245B2 (https=) |
| EP (1) | EP1135496B1 (https=) |
| JP (1) | JP2002533062A (https=) |
| AT (1) | ATE492640T1 (https=) |
| AU (1) | AU774760B2 (https=) |
| CA (1) | CA2349839C (https=) |
| DE (1) | DE69943058D1 (https=) |
| WO (1) | WO2000032624A2 (https=) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4775662A (en) | 1983-03-07 | 1988-10-04 | Smithkline Beckman Corporation | Leukotriene antagonists |
| US5010003A (en) | 1983-04-25 | 1991-04-23 | Genentech, Inc. | Use of yeast homologous signals to secrete heterologous proteins |
| IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
| US5663304A (en) | 1993-08-20 | 1997-09-02 | Genentech, Inc. | Refolding of misfolded insulin-like growth factor-I |
| US5407810A (en) | 1993-08-20 | 1995-04-18 | Genentech, Inc. | Aqueous multiple-phase isolation of polypeptide |
| US5861485A (en) | 1994-08-23 | 1999-01-19 | Millennium Pharmaceuticals, Inc. | Polypeptides involved in body weight disorders, including obesity |
| US6534631B1 (en) * | 1998-07-15 | 2003-03-18 | Human Genome Sciences, Inc. | Secreted protein HT5GJ57 |
| AU7466198A (en) * | 1997-04-09 | 1998-10-30 | Beth Israel Deaconess Medical Center | Ucp3: an uncoupling protein homologue |
| JP2002502240A (ja) | 1997-05-20 | 2002-01-22 | メルク エンド カンパニー インコーポレーテッド | ヒト脱共役タンパク質3 |
| WO2000004037A1 (en) | 1998-07-14 | 2000-01-27 | Amylin Pharmaceuticals, Inc. | Uncoupling protein 4 (ucp-4) and methods of use |
-
1999
- 1999-11-03 AU AU14667/00A patent/AU774760B2/en not_active Expired
- 1999-11-03 AT AT99973036T patent/ATE492640T1/de not_active IP Right Cessation
- 1999-11-03 CA CA2349839A patent/CA2349839C/en not_active Expired - Lifetime
- 1999-11-03 JP JP2000585265A patent/JP2002533062A/ja active Pending
- 1999-11-03 WO PCT/US1999/025947 patent/WO2000032624A2/en not_active Ceased
- 1999-11-03 DE DE69943058T patent/DE69943058D1/de not_active Expired - Lifetime
- 1999-11-03 EP EP99973036A patent/EP1135496B1/en not_active Expired - Lifetime
-
2002
- 2002-10-15 US US10/270,861 patent/US6967245B2/en not_active Expired - Lifetime
-
2008
- 2008-02-04 US US12/012,569 patent/US20080312417A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002533062A (ja) | 2002-10-08 |
| CA2349839C (en) | 2013-10-08 |
| EP1135496B1 (en) | 2010-12-22 |
| AU1466700A (en) | 2000-06-19 |
| WO2000032624A3 (en) | 2000-11-09 |
| WO2000032624A2 (en) | 2000-06-08 |
| EP1135496A2 (en) | 2001-09-26 |
| US20030077749A1 (en) | 2003-04-24 |
| US20080312417A1 (en) | 2008-12-18 |
| AU774760B2 (en) | 2004-07-08 |
| CA2349839A1 (en) | 2000-06-08 |
| US6967245B2 (en) | 2005-11-22 |
| ATE492640T1 (de) | 2011-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1999055868A3 (en) | Fizz proteins | |
| ATE447583T1 (de) | Polypeptide und dafür kodierende nukleinsäure | |
| ATE519847T1 (de) | Il-17-homologe polypeptide und ihre therapeutische verwendung | |
| WO1999061469A3 (en) | Prostate growth-associated membrane proteins | |
| MXPA01002592A (es) | Polipeptidos de transmembrana y secretados y acidos nucleicos que codifican los mismos. | |
| KR100468977B1 (ko) | 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산 | |
| DE60137829D1 (de) | Menschliche stra6 polypeptide | |
| WO2000039297A3 (en) | Il-1 related polypeptides | |
| DE69943058D1 (de) | Loslösendes protein 5 - ucp5 | |
| EP1241179A3 (en) | Human cornichon-like protein and nucleic acids encoding it | |
| EP1251139A3 (en) | Human mindin-like protein and nucleic acids encoding it | |
| PT1241251E (pt) | Proteína semelhante a prostasina humana e ácidos nucleicos que a codificam | |
| ATE415422T1 (de) | Menschliches gas-6 (growth arrest-specific gene 6) protein und dafür kodierende nukleinsäuren | |
| EP1247817A3 (en) | Human CD23-like protein and nucleic acids encoding it | |
| EP1241252A3 (en) | Human enteropeptidase-like protein and nucleic acids encoding it | |
| ATE402954T1 (de) | Menschliches a33-antigen-ähnliches protein und dafür kodierende nukleinsäure | |
| EP2050762A3 (en) | Human cornichon-like protein and nucleic acids encoding it | |
| ATE404585T1 (de) | Menschliches synaptogyrin-ähnliches protein und dafür kodierende nukleinsäure | |
| ATE405590T1 (de) | Menschliches hcar-ähnliches protein und dafür kodierende nukleinsäure | |
| EP1241250A3 (en) | Human dehydrogenase-like protein and nucleic acid encoding it | |
| EP1241185A3 (en) | Human protocadherin-like protein and nucleic acids encoding it | |
| DE60043258D1 (de) | Menschliches suppressor von fused | |
| DE69827532D1 (de) | Polypeptide und dafür kodierende Nukleinsäure |